Marina Frimer
Papers
2
Total Citations
11
H-Index
2
About
Marina Frimer is a gynecologic oncologist whose research focuses on rare cervical malignancies and optimizing perioperative care in gynecologic cancer surgery. Her most cited work, a 2020 case study on non-HPV related primary endometrioid adenocarcinoma of the cervix, addresses a critical gap in the literature—highlighting the diagnostic challenges and misclassification of this rare tumor subtype. By applying a newly developed classification system, Frimer’s contribution helps clarify diagnostic criteria for this uncommon malignancy, providing a framework that aids pathologists and clinicians in accurate identification. This paper has garnered 9 citations, reflecting its niche but essential impact on the field. More recently, Frimer has investigated the addition of metronidazole to standard perioperative antibiotic prophylaxis during hysterectomy for gynecologic cancers, a 2025 study that aims to reduce infectious complications in this high-risk population. Her work bridges rare disease characterization with practical surgical management, demonstrating a commitment to both advancing pathological understanding and improving immediate patient outcomes. Frimer’s research is particularly valuable for clinicians navigating the complexities of gynecologic oncology, from rare tumor classification to evidence-based perioperative protocols.
Research Focus
Key Achievements
Top Papers
- 1
- 2